ClearPoint Neuro, Inc. (CLPT) stock
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3012% above fair value
$7.71−0.15 (-1.91%)
Close on Nov 18, 2026Market cap $247.14MP/E –Yield –
ClearPoint Neuro operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
ClearPoint Neuro's operating income for the twelve months ending Sep 30, 2026 was -$32.10M. For fiscal 2025 it was -$24.16M. The highest annual figure on record is -$3.13M in fiscal 2012.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$24.16M | – |
| FY2024 | Dec 31, 2024 | -$19.73M | – |
| FY2023 | Dec 31, 2023 | -$22.45M | – |
| FY2022 | Dec 31, 2022 | -$16.33M | – |
| FY2021 | Dec 31, 2021 | -$13.37M | – |
| FY2020 | Dec 31, 2020 | -$6.22M | – |
| FY2019 | Dec 31, 2019 | -$4.59M | – |
| FY2018 | Dec 31, 2018 | -$5.25M | – |
| FY2017 | Dec 31, 2017 | -$6.34M | – |
| FY2016 | Dec 31, 2016 | -$7.49M | – |
| FY2015 | Dec 31, 2015 | -$8.97M | – |
| FY2014 | Dec 31, 2014 | -$5.32M | – |
| FY2013 | Dec 31, 2013 | -$7.47M | – |
| FY2012 | Dec 31, 2012 | -$3.13M | – |
| FY2011 | Dec 31, 2011 | -$5.92M | – |
| FY2010 | Dec 31, 2010 | -$9.52M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$6.33M | – |
| Q2 FY2026 | Jun 30, 2026 | -$10.24M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.48M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.05M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.28M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.68M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.16M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.64M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.16M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.72M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.22M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.71M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.90M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.13M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.71M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.47M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.80M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.20M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.86M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.98M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.80M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.41M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.18M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.27M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.27M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.48M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.21M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.42M | – |
| Q3 FY2019 | Sep 30, 2019 | -$910.53K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.29M | – |
| Q1 FY2019 | Mar 31, 2019 | -$972.25K | – |
| Q4 FY2018 | Dec 31, 2018 | -$979.02K | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.21M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.64M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.43M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.83M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.33M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.82M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.35M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.79M | – |
See a number that looks wrong?